subscribeSubscribe
Novartis` asciminib bests Pfizer`s Bosulif in phase 3 leukemia trial

Novartis` asciminib bests Pfizer`s Bosulif in phase 3 leukemia trial
Nick P.Taylor FIERCE BIOTECH
27 Aug 2020
Share Share
EMA’s CHMP Recommends Five New Medicines for Approval

EMA’s CHMP Recommends Five New Medicines for Approval
Ana Mulero RAPS
26 Feb 2018
Share Share
First-line use of Pfizer’s Bosulif cleared in the US

First-line use of Pfizer’s Bosulif cleared in the US
Selina McKee PHARMA TIMES
21 Dec 2017
Share Share
Pfizer, Avillion file for Bosulif expansion

Pfizer, Avillion file for Bosulif expansion
Selina McKee PHARMA TIMES
31 Aug 2017
Share Share
Pfizer`s Ibrance faces tough review at NICE, U.K. exec worries

Pfizer`s Ibrance faces tough review at NICE, U.K. exec worries
Eric Sagonowsky FIERCE PHARMA
28 Nov 2016
Share Share
Eisai Latest Cancer Drugmaker to Win UK Approval After Price Cut

Eisai Latest Cancer Drugmaker to Win UK Approval After Price Cut
Ben Hirschler REUTERS
03 Nov 2016
Share Share
Pfizer’s Bosulif wins NICE backing after new discount offer

Pfizer’s Bosulif wins NICE backing after new discount offer
Eric Sagonowsky FIERCE PHARMA
07 Jul 2016
Share Share
BCR-ABL Tyrosine Kinase Inhibitors - Risk of Hepatitis B Reactivation

BCR-ABL Tyrosine Kinase Inhibitors - Risk of Hepatitis B Reactivation
HEALTH CANADA
06 May 2016
Share Share
Health Canada Require Updated Warning on Gleevec Labeling for Brand and Generics

Health Canada Require Updated Warning on Gleevec Labeling for Brand and Generics
TWOFOUR INSIGHT
05 May 2016
Share Share
NHS watchdog takes issue with Pfizer exec`s role on foundation trust`s board

NHS watchdog takes issue with Pfizer exec`s role on foundation trust`s board
Tracy Staton FIERCE PHARMA
20 Jan 2016
Share Share